AI assistant
Mersana Therapeutics, Inc. — Director's Dealing 2017
Jun 28, 2017
34702_dirs_2017-06-27_950b686c-63d1-472f-97d8-1d521d69d288.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Mersana Therapeutics, Inc. (MRSN)
CIK: 0001442836
Period of Report: 2017-06-27
Reporting Person: Lowinger Timothy B (Chief Scientific Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to purchase Common Stock | $6.98 | 2018-03-03 | Common Stock (5911) | Direct | |
| Option to purchase Common Stock | $7.43 | 2021-05-11 | Common Stock (5111) | Direct | |
| Option to purchase Common Stock | $1.40 | 2022-10-01 | Common Stock (103333) | Direct | |
| Option to purchase Common Stock | $1.40 | 2024-01-09 | Common Stock (11111) | Direct | |
| Option to purchase Common Stock | $1.53 | 2025-06-11 | Common Stock (128118) | Direct | |
| Option to purchase Common Stock | $4.10 | 2026-08-29 | Common Stock (45854) | Direct |
Footnotes
F1: The options vested 25% on February 11, 2009 and in equal quarterly installments thereafter.
F2: The options vested 25% on May 12, 2012 and in equal quarterly installments thereafter.
F3: The options vested 25% on August 1, 2013 and in equal quarterly installments thereafter.
F4: The options vest in equal quarterly installments over the first four years after the vesting commencement date, March 31, 2014.
F5: The options vest in equal quarterly installments over the first four years after the vesting commencement date, June 12, 2015.
F6: The options vest in equal quarterly installments over the first four years after the vesting commencement date, July 1, 2016.